Cambridge Investment Research Advisors’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55K | Buy |
20,950
+3,000
| +17% | +$7.88K | ﹤0.01% | 3532 |
|
|
2025
Q1 | $54K | Buy |
+17,950
| New | +$54K | ﹤0.01% | 3400 |
|
|
2024
Q4 | – | Sell |
-14,519
| Closed | -$54K | – | 3535 |
|
|
2024
Q3 | $54K | Buy |
14,519
+700
| +5% | +$2.6K | ﹤0.01% | 3325 |
|
|
2024
Q2 | $87K | Sell |
13,819
-631
| -4% | -$3.97K | ﹤0.01% | 3171 |
|
|
2024
Q1 | $78K | Sell |
14,450
-500
| -3% | -$2.7K | ﹤0.01% | 3175 |
|
|
2023
Q4 | $75K | Hold |
14,950
| – | – | ﹤0.01% | 3067 |
|
|
2023
Q3 | $25K | Hold |
14,950
| – | – | ﹤0.01% | 3074 |
|
|
2023
Q2 | $42K | Buy |
14,950
+1,000
| +7% | +$2.81K | ﹤0.01% | 3091 |
|
|
2023
Q1 | $25K | Buy |
13,950
+2,000
| +17% | +$3.58K | ﹤0.01% | 3091 |
|
|
2022
Q4 | $61K | Buy |
+11,950
| New | +$61K | ﹤0.01% | 2960 |
|
|
2021
Q3 | – | Sell |
-28,568
| Closed | -$408K | – | 3144 |
|
|
2021
Q2 | $408K | Buy |
+28,568
| New | +$408K | ﹤0.01% | 2219 |
|